ResApp raises $12.5M for its mobile-enabled respiratory disease tool

The funds will be used to expedite an FDA approval for the adult diagnostic test, expand into in-clinic use, and enter European and Asian markets.
ResApp Health

Doctors Without Borders to evaluate ResAppDx in a low income setting

Developed by ResApp Health, the ResAppDx app can diagnose pneumonia and other common respiratory diseases in children.